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The influence of specific pretreatment variables (i.e., age, gender, birth order, number of
children in the family, and family history of enuresis) on outpatient urine alarm treatment
outcomes was examined. A total of 186 Israeli children between the ages of 4 to 7
participated in the study, and of those, 55 children were 4 years old. The entire sample
was used to test the age-related pretreated variable, and all other pretreatment variables
were solely analyzed using the sample of 4-year-old children at the time of treatment.
The data were derived from two different sources: (a) treatment files from a clinical
psychologist, and (b) a six question telephone survey.
Statistical analysis revealed
evidence that family history is a positive predictor of urine treatment outcomes in young
children. For young children with a family history of bedwetting, 71.9% were dry posttreatment, while only 43.5% of young children without a family history of bedwetting
were dry post-treatment. Other statistical analysis showed no evidence (p > .05) of
pretreatment variables’ (i.e., age, gender, birth-order, and number of children in the
family) influence on urine alarm treatment outcomes in young children. The findings
indicate that, in young children, a family history of bedwetting is a positive predicator for
urine alarm treatment outcomes. Pediatricians and other pediatric health practitioners are
encouraged to treat young children with a family history of bedwetting with a urine alarm
treatment approach.
Key Words: bedwetting, alarm treatment, pre-treatment variables, young bedwetting
children
Enuresis, more familiarly referred to as bedwetting, is one of the most widespread
(Nappo et al., 2002; Rogers, 2002) and chronic childhood disorders affecting 7% to 22 %
children by age seven (Butler & Holland, 2000). Boys are more affected by this disorder
than girls of the same age. The cause of enuresis is variously understood as being
multifaceted and multi-factorial (El-Radhi, 2005; Thiedke, 2003). Sources of causation
for enuresis development include a low level of the antidiuretic hormone (ADH)
vasopressin (Butler, 1994), reduction in functional bladder capacity (Kawauchi et al.,
2003; Yeung, Chiu, & Sit, 1999), lack of sleep arousal (Neveus, 2003; Wolfish, 1999),
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genetic factors (Eiberg, Berendt, & Mohr, 1995; Von Gontard, Hollmann, Rittig, &
Lehmkul, 1997; Von Gontard, Eiberg, Hollmann, Rittig, & Lehmkuhl, 1998; Von
Gontard, Eiberg, Hollmann, Rittig, & Lehmkuhl, 1999), delayed maturation (Fergusson,
Horwood, & Shannon, 1986; Fritz et al., 2004), and psychological factors (Hagglof,
Andren, Bergstrom, Marklund, & Wendelius, 1998; Theunis, Van Hoecke, Paesbrugge,
Hoebeke, & Vander Walle, 2002).
Several treatment options are available for addressing bedwetting symptoms,
including pharmacology, alternative therapies, and behavioral interventions with or
without using a urine alarm system. To date, the urine alarm system remains the superior
treatment modality for bedwetting symptoms (Boris, & Dalton, 2004; Houts, Berman, &
Abramson, 1994) with successful outcome rates ranging between 65%-75% (Butler &
Glasson, 2005). In the past, different outcome predicting pretreatment (OPP) variables for
urine alarm treatment have been established (e.g., severity of wetting episodes,
concurrent daytime wetting episodes, family stress, and lack of motivation) (Butler &
Robinson, 2002). OPP variables can be instrumental in identifying existing conditions
that either support or hinder urine alarm treatment (Moffat & Cheang, 1995), thus making
OPP variables valuable from a clinical as well as a research perspective.
Earlier studies have been conducted on OPP variables (Butler, Redfern, &
Forsythe, 1990; Butler & Robinson, 2002; Devlin & O’Cathain, 1990; Dische, Yule,
Corbett, & Hand, 1983; Fielding, 1985). Comparing the results of these studies is
complex because most studies vary significantly in outcome measures and age of study
participants. Overall, in the cited studies, the age of the study participants varied from age
4.8 to age 17 and outcome measures to establish dryness varied from 14 consecutive
nights to 6 weeks of consecutive dryness, with most studies defining initial treatment
success at 14 consecutive dry nights (Butler et al., 1990; Butler & Robinson, 2002;
Fielding, 1985), while other studies define treatment success as 21 consecutive dry nights
during the treatment followed by 21 consecutive nights post treatment (Dische et al.,
1983), or 42 consecutive dry nights (Devlin & O’Cathain, 1990).
In the 1980s, Dische and associates (1983) and Fielding (1985) researched
different variables associated with treatment outcome for alarm treatment. Dische’s et al.
(1983) study included 113 children ranging in age from 4.8 to 13.2 years. Pretreatment
factors related to treatment outcome included age, gender, birth order, family size, social
class, child’s behavior rated by a parent, child’s behavior rated by a teacher, previous
treatment for enuresis, secondary or primary enuresis, presence of urinary infection,
diurnal wetting episodes, encopresis, family difficulties, unsatisfactory housing
conditions, and severe financial hardship. The results of the study indicated only two
OPP variables-unsatisfactory housing conditions and family difficulties–had an adverse
effect on initial treatment success, while relapse and long term treatment outcomes were
adversely influenced by deviant behavior scores on the teacher rating scale and family
difficulties. All other tested pretreatment variables were found unrelated to treatment
outcome.
Fielding (1985) studied pretreatment variables associated with enuresis treatment
failure. The study accepted 52 children ranging in age from 5 to 17 years. Thirty
different pretreatment variables, including variables deriving from socio-demographic
data, enuresis history, family history of enuresis, social background, and behavioral
problems, were researched. The findings indicated that only three variables had an
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adverse effect on initial treatment outcome, including frequency of micturition, urgency
of micturition, and a previous experience with enuresis alarm treatment.
Butler et al. (1990) investigated urine alarm treatment outcomes in 55 children
ranging in age from 6.9 to 14.7 years. The researchers studied various pretreatment
variables, including personal data, mother’s tolerance, willingness of the child to change,
resistance to change, family reaction, and secrecy. Findings indicated that positive
treatment outcome was associated with the child understanding enuresis psychologically
and showing no resistance to change, while treatment success declined where there was
evidence of resistance to change. Devlin and O’Cathain (1990) analyzed predicting
variables for urine alarm treatment in 96 children ranging in age from age 6 to 17 years.
For this study, four different categories of pretreatment variables were used (sociodemographic data, history of enuresis, data about possible physical/psychiatric disorders
and family stress were analyzed), and findings indicated that three stress related
pretreatment variables (i.e., family stress, little or no distress of the child about the
bedwetting, and developmental delay in the child) had a negative influence on urine
alarm treatment outcome.
A third instructive study by Butler and Robinson (2002) analyzed pretreatment
variables for enuresis alarm treatment in 66 children ranging in age from 6 to 16 years.
Pretreatment variables included age, gender, severity of wetting, and functional bladder
capacity. In this study, only functional bladder capacity was identified as a negative
predictor for enuresis alarm treatment outcome.
In the reviewed studies, specific pretreatment variables, including age (Butler &
Robinson, 2002; Butler et al., 1990; Dische et al., 1983; Devlin & O’Cathain, 1990;
Fielding, 1985), gender (Butler & Robinson, 2002; Butler et al., 1990; Dische et al.,
1983; Devlin & O’Cathain, 1990; Fielding, 1985), birth order (Dische et al., 1983; Devlin
& O’Cathain, 1990; Fielding, 1985), family size (Dische et al., 1983, Devlin &
O’Cathain, 1990), or family history (Fielding, 1985) were found to be unrelated to
enuresis alarm treatment outcomes. Based on this inconclusive history of enuresis
research, questions arise regarding the identification of urine alarm pretreatment variables
especially for younger children. Research that provides a degree of clarity on the nature
of enuresis pretreatment variables can inform key aspects of the intervention process
including family settings, parent understanding of the nature of enuresis, parent and
parent-child education regarding the treatment process that is developmentally
appropriate. It also can provide pediatricians and other pediatric health practitioners with
tools to better prepare families for the treatment regiment and help set appropriate
expectations for treatment outcomes.

Focus of the Study
This study focused on the analysis of interactions of five different OPP variables
(i.e., gender, birth order, numbers of siblings in a family, family history of bedwetting,
and age) and urine alarm treatment for 4-year-old children. While the OPP variables
gender, birth-order, numbers of siblings in a family, and family history of bedwetting
were solely analyzed on the study sample of children age four, the OPP variable age was
analyzed utilizing the entire study sample including children age four to seven.
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Method
Participants
In this study, 400 bedwetting children, aged 4-7 years, and treated by a clinical
psychologist in Israel, were randomly chosen to be included in the study sample. These
children were randomly selected from a population pool of 948 bedwetting children
under treatment at fourteen urine alarm treatment offices in Israel. Inclusion criteria for
participation in the study was determined by the following criteria: each child started
treatment between June 1, 2003 and May 31, 2004; the child was receiving or had
received urine alarm treatment only (i.e., no additional medication was prescribed) during
the initial treatment session; the child was at least 4 years of age and not older than 7
years of age; the child was diagnosed with enuresis or the child was 4 years of age and
met the criteria for enuresis described in the Diagnostic and Statistical Manual of Mental
Disorders, (DSM-IV-TR; American Psychiatric Association [APA], 2000) with the
exception of the age limit.
Of the 400 potential study participants only 265 could be contacted and of those
50 potential participants refused to participate in the study and 29 potential participants
were excluded from the study for various reasons. Ultimately, the study sample was
comprised of 186 participants, with 112 male participants and 74 female participants.
Treatment
All children received urine alarm treatment from the same clinical psychologist in
one of the fourteen bedwetting clinics in Israel. Each child participated in a combined
assessment and treatment session. The initial session included diagnosis, a short and
general education about the disorder, introduction to treatment, demonstration of the
urine alarm device, explanation of the use of a daily progress chart, and discussion of
arrangements for follow up. Follow-up treatment was made available in a face-to face
format, via telephone consultation, or review and response to fax, letter, or e-mail
inquires directed to the treating clinical psychologist. During follow-up sessions, progress
was evaluated with the use of the daily progress chart combined with information from
the child and the attending adult. When necessary, a multiple waking exercise was
introduced with those children having difficulties waking up to the alarm. The treatment
was considered to be successfully completed after the achievement of 21 consecutive dry
nights. Parents were instructed to monitor the child for relapse, and when relapse
occurred, to return to the office and restart the urine alarm treatment under clinical
supervision.
Procedure
Data for this study originated from two sources: the treatment files of the clinical
psychologist and from a telephone survey of the clients (i.e., parents of the children
receiving treatment). Treatment file data was generated by the clinical psychologist who
recorded the information during the initial assessment and treatment session.
Demographic data was also derived from this source and included: age of the child,
gender, birth order, the family history of bedwetting symptoms [mother, father, sibling,
uncle, aunt, grandparent having suffered (or are currently suffering) from bedwetting
symptoms], and information about prescribed medication (e.g., Minirine or Elatrolet)
used during the urine alarm treatment.
The second data source was derived using a telephone survey methodology. A
survey was constructed that consisted of six questions inquiring about the number of
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wetting episodes during the last month, supplementary enuresis medication, and possible
additional enuresis treatment.
The telephone survey items were reviewed and subsequently revised by three
clinical psychologists experienced in treating enuretic children with the urine alarm
method in Israel to ensure the content validity of the instrument (Sproull, 2002). In
addition, a pilot telephone survey was conducted using the survey instrument with 20
children to ensure that the text of the survey reflected content validity (i.e., it was easy to
understand and used simple to follow questions). Following analysis of the pilot study
data and completion of survey instrument revision, the study was implemented in spring
of 2005.
The telephone survey was conducted by an agency specialized in data collection,
and the data collection was supervised by the treating clinical psychologist. The
interviewers made a maximum of four attempts to reach a parent of each study subject.
Data derived from the telephone survey included: treatment success (defined by less than
three wetting episodes during the previous month), treatment failure (defined by three or
more wetting episodes during the previous month), identification of medication taken to
control bedwetting symptoms during urine alarm treatment, and whether the child
received additional bedwetting treatment after the urine alarm treatment.
Data Analysis
Descriptive statistics were employed for analyzing the study population. One-way
analysis of variance [ANOVA] was used to ascertain the success rate of the urine alarm
treatment for the total study population. The data of the 4-year-olds was then extracted
from the data pool, and an analysis of pretreatment variables for this population was
undertaken using logistic regression (birth order, number of children in a family, genetic
predisposition) to examine a possible relationship between each of these variables and
treatment outcome. Further, age as a pretreatment variable was examined by comparing
the relationship of treatment outcomes in children ages 4 to 7 using a chi-square test of
independence and an analysis of variance.

Results
The pool of study participants totaled 186. This total was derived from an initial
pool of 400 children randomly chosen for the study from the total population of 948
children treated for enuresis. Children taking medication to control bedwetting symptoms
such as Minirine, Elatrolet, or any other medication in support of the urine alarm
treatment were excluded from the study. From the 400 randomly chosen study
participants, 135 could not be contacted via telephone and therefore were excluded from
the study. A total of 265 children were contacted via the telephone survey. Fifty declined
participation, while 215 participants consented to participate. Of this derived number of
215 participants, 29 were excluded for specific reasons (i.e., 21 were taking additional
medication; 4 did not compete the questions; 2 did not start treatment; 2 were adopted
children).
Sample Description
The mean age of the study participants (N = 186) was 5.5 years (M = 5.45, SD =
1.15) with an age range from age 4 to age 7. Overall, 112 boys and 74 girls participated
in the study, representing a male/female percentage ratio of 60/40. Participating children
were largely first or second born children with 52.2% first born (n = 97), 31.2% second
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born (n = 58), 11.3% third born (n = 21), 2.7% fourth born (n = 4) and 2.7% fifth born (n
= 4). The children had an average of 1.5 siblings with 9.7 % (n = 18) of participating
children having no siblings, 49.5% (n =92) of the children having one sibling, 26.5% (n =
49) of the children having two siblings, 7.5% (n = 14) of the children having three
siblings, 6.5% (n = 12) of the children having four siblings, and 0.5% (n = 1) of the
children having seven siblings. Children from families with a history of bedwetting
symptoms totaled 123 (67%). Post treatment, 64.5% (n = 120) of the participants
achieved dryness, defined as not more than 0 to 2 wetting incidents in the last month, and
35.5% (n = 66) participants wet their beds three or more times in a month, thus not
achieving dryness.
Subset sample description of 4-year-olds
Fifty-five children age four were included for the analysis of pretreatment
variables. Of those, 52% (n = 29) were male and 47.3% (n = 26) female. With reference
to birth order, the majority of study participants in the group of 4–year-olds were first
born (61.8%, n = 34), 29.1% (n = 16) second born children, 7.3% (n = 4) third born
children, and 1.8% (n = 1) a fourth born child. Most children (56.4%, n = 31) had one
sibling, while 16.3% (n = 9) had no sibling(s), 18.2% (n = 10) had two siblings, 7.3% (n
= 4) had three siblings, and one study participant (1.8%, n = 1) had four siblings. Of the
children in this age group, 58.2% (n = 32) had a family history of bedwetting, and 41.8%
(n = 23) reported no family history. Children achieving dryness included 60% or 33
children in this subset of 4 year-olds, while 40% (n = 22) children presented with
bedwetting symptoms post treatment.
Variables associated with treatment outcome in 4-year-olds
Gender was found to have no influence on treatment outcome in children age four
receiving enuresis alarm treatment. The group of 4-year-olds consisted of 52.7% (n =29)
male participants and 47.3% (n =26) female participants. Post treatment, 34.5% (n = 19)
boys and 25.5% (n =14) girls achieved dryness, while 18.2% (n =10) of the boys and
21.8% (n = 12) of the girls still suffered from bedwetting. Logistical regression analysis
was conduced with the treatment outcome as the dependent variable and gender as the
independent variable. The logistic regression slope coefficient for gender was negative (B
= -.488) indicating that girls were less likely to be dry post-treatment. However, results of
the Wald statistic = .77, p = .38 showed that this slope coefficient was not statistically
significant.
Birth order is not a predicting variable for treatment outcome in 4-year-olds.
Logistical regression analysis was conduced with the treatment outcome as the dependent
variable and birth order as the independent variable. This group of 4-year-olds consisted
of 61.8% (n =34) first born children, 29.1% (n =16) second born children, 7.3% (n =4)
third born children and 1.8% (n =1) fourth born children. Of the first born children post
treatment, 40% (n =22) achieved dryness, while 21.8% (n =12) continued to suffer from
bedwetting. In the group of second born children, 16.4% (N =9) achieved dryness post
treatment, while 12.7% (n =7) persisted with bedwetting symptoms. In the group of third
born children, 3.7% (n =2) achieved dryness post treatment, while3.6% (n =2) did not. In
the last group of fourth born children, none (n = 0) achieved dryness post treatment,
while 1.8% (N =1) still suffered from bedwetting symptoms. Overall, enuresis alarm
treatment was most successful in first born children. The logistic regression analysis
indicted a negative (B = -.478) logistic regression slope coefficient for birth order in
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children age 4, suggesting that latter-born children were less likely to be dry post
treatment. However, as indicated by the results of the Wald statistic = 1.48, p = .23, the
slope coefficient was not statistically significant.
The number of siblings in a family is unrelated to treatment outcome in children
age 4. The group of 4-year-olds consisted of 16.4% (n =9) children without siblings,
56.3% (n = 31) with one sibling, 18.2% (n =10) with two siblings, 7.3% (n = 4) with
three siblings, and 1.8% (n = 1) with one sibling. The logistic regression analysis indicted
a negative (B = -.322) logistic regression slope coefficient, suggesting that children with
the least number of siblings were more likely to be dry post treatment compared to
children with two or more siblings. However, the Wald-statistic = 1.01, p = .23 indicated
that the coefficient slope coefficient was not statistically significant.
Family history of enuresis is a predictor for positive enuresis alarm treatment in
children age 4. The group of 4–year-olds included 41.8% (n =23) children without a
family history of enuresis and 58.2% (n =32) children with a family history of bedwetting
defined as at least one of the following family members suffering or have suffered in the
past from enuresis (i.e., father, mother, sibling, aunt, uncle, grandmother, or grandfather).
The logistic regression slope for a family history of enuresis was positive (B = 1.201),
indicating that a child with enuresis in the extended family was more likely to be dry post
treatment compared to children without a family history of enuresis. Wald-statistic =
4.35, p = .04 showed statistical significance of the logistic regression slope coefficient.
To further understand the relationship between family history of enuresis and
treatment outcomes, a cross-tabulation (see Table 1) and chi-square was employed to
investigate the relative frequencies of treatment outcomes as a function of family history.
The analysis showed that children age 4 with a family history of enuresis (71.9%) are
more likely to be dry post treatment compared to children without family history of
enuresis (43.5%).

Table 1
Cross-Tabulation of Genetic Predisposition and Treatment Outcome in
4-Year-Old Children
Treatment Outcome
Dry
Wet
No Family History

10 (43.5%)

13 (56.5%)

Family History

23 (71.9%)

9 (28.1%)

Age was unrelated to treatment outcome, indicated by similar treatment success
rates of all age groups from the sample. Two different, yet complementary, statistical
analyses were employed in support of this finding. First, a chi-square test of
independence was used to test the relationship between age and treatment outcome
variables. Second, ANOVA was utilized to compare mean success rates for all age
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groups followed by a cross tabulation of the child’s age in years and treatment outcome
was performed (see Table 2) to summarize these observations. The chi-square test of
independence analysis found no statistical evidence that the treatment effectiveness
varied by age, 2 (3, n = 186) = .83, p = .84,  v = .07. Overall, the percentage of children
achieving post treatment dryness for the 4, 5, 6, and 7-year-olds was 60.0%, 66.7%,
68.0%, and 64.4%, respectively. The results of the ANOVA analyses, that compared the
mean success rates for all four treatment groups, found no statistical evidence that the
post treatment success rates varied by age group F (3, 182) = 0.27, p = .85.

Table 2
Cross-Tabulation of Child’s Age and Treatment Outcome
Child Age
in Years
4.00

Total N
55

Treatment Outcome
Dry (N/%)
Wet (N/%)
33 (43.5%)
22 (56.5%)

5.00

36

24 (66.7%)

12 (33.3%)

6.00

50

34 (68.0%)

16 (32.0%)

7.00

45

29 (64.4%)

16 (35.6%)

Discussion
Data analysis indicates that for 4-year-olds, the studied pretreatment variables of
age, birth order, and number of children in the family did not predict treatment outcome.
The findings replicate the results of earlier studies on the same pretreatment variables in
older children (Dische et al., 1983; Jensen & Kirstensen, 2001). However, a positive
family history of enuresis was found to be an important predictor of positive treatment
outcome in 4-year-olds, with results indicating that the treatment was most successful in
4-year-old children with a family history (72%) of bedwetting, while less effective for
children age 4 without a family history (43.5%) of bedwetting. The reason for this
discrepancy in treatment outcomes in 4-year-olds with or without a family history of
bedwetting was not addressed in this study.
Superior treatment outcomes for children with a positive family history of
bedwetting may be linked to parental attitudes toward bedwetting and/or greater parental
involvement and compliance with the treatment regiment. Parents who have first hand
experience with the issue might better understand the impact that involuntary wetting can
have on a child. Such a personal history might lead to a greater sensitivity to the child’s
experience and encouragement for the child to comply with the treatment protocol.
Essential to a positive treatment outcome is use of the urine alarm treatment
consistently (i.e., each night) for a time period of 2 to 6 months (Gimpel & Warzak,
1998). The length of the treatment regimen, combined with the demands of a nightly
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routine, requires sustained motivation on the part of the child and his or her family. It is
possible that parents who are familiar with the problem understand the significance of a
positive treatment outcome and are therefore able to facilitate the child’s motivation to
comply with the treatment regimen until dryness is achieved.
Conversely, the marginal success rate for children without a family history of
bedwetting might be related to the parent’s role in understanding the problem and
importance of treatment compliance. Further, parents unfamiliar with the problem might
assume that the child has at least some conscious control over his or her bladder function
and that the child is either too lazy or simply not willing to exercise control. On the other
hand, parents with a family history of bedwetting tend to know that bedwetting is not
intentional nor can it be controlled through cognition, desire, wish fulfillment, or trying
harder to remain dry. As indicated, the difference in parental first hand experience
identified in this study suggests a number of implications for treating enuresis; e.g.,
focused parent education that addresses parental attitudes toward the disorder and the
potential impact these feelings may have on treatment compliance, persistence, and
consistency.
While this analysis of the age related pretreatment variable indicated that age is
not a predicator for urine alarm treatment outcomes in children age four, the study does
suggest that the applied urine alarm treatment is similarly effective for children age 4 to
age 7. Current pediatric (Boris & Dalton, 2004) and psychiatric diagnostic guidelines
(American Psychiatric Association [APA], 2000) require a minimum age of 5 years for a
diagnosis of enuresis implying that the earliest start of urine alarm treatment is set at age
5.
However, research indicates prolonged suffering from symptoms of bedwetting
increases the probability for a child to develop behavioral and emotional problems
(Fergusson & Horwood, 1994). In addition, other research stipulates only a 6%
probability for a 4-year-olds to become dry without intervention in the next year (Oppel,
Harper, & Rider, 1968).
In view of the implied limits on use of the urine alarm system to treat enuresis for
children, the present study provides some evidence that urine alarm treatment is
successful for children age 4, especially for those who have a family history of this
disorder. As a consequence of these findings, pediatricians and other health practitioners
are encouraged to rethink treatment guidelines for bedwetting children and to offer urine
alarm treatment to motivated parents with eneuretic 4-year-old children.
Clinical implications for 4-year-olds without a family history of bedwetting are
less clear. However, when confronted with the question of whether to start treating a
child at age 4 with the urine alarm system, clinicians should take into consideration the
finding that children without a family history of bedwetting have a 45% probability of
success. While this probability is not as impressive as that for 4-year-old children with a
family history of enuresis (i.e., 72% success rate), it does suggest the potential benefit of
parent education about enuresis as a potentially effective strategy to increase parent
sensitivity to the causative factors to childhood enuresis. With a heightened
understanding and awareness of this information, parents without a personal history of
enuresis may increase sensitivity to the child’s needs for support during treatment for
bedwetting.
Because this study was conducted in Israel through a single clinical psychologist,
future research could explore the research questions across several practice settings; e.g.,
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outpatient pediatric urologic clinics, multiple pediatrician practice settings. In addition,
study of enuresis treatment outcomes in additional culturally diverse populations would
be instructive. Further investigation of early age urine alarm treatment outcomes in
the United States with children as young as 4 years of age is warranted based upon these
results.
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